Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy

被引:98
作者
Li, Xiao-Feng [1 ]
Carlin, Sean [1 ]
Urano, Muneyasu [1 ]
Russell, James [1 ]
Ling, C. Clifton [1 ]
O'Donoghue, Joseph A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
关键词
D O I
10.1158/0008-5472.CAN-06-4353
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor hypoxia is commonly observed in primary solid malignancies but the hypoxic status of subclinical micro-metastatic disease is largely unknown. The distribution of hypoxia in microscopic tumors was studied in animal models of disseminated peritoneal disease and intradermal (i.d.) growing tumors. Tumors derived from human colorectal adenocarcinoma cell lines HT29 and HCT-8 ranged in size from a few hundred microns to several millimeters in diameter. Hypoxia was detected by immunofluorescent visualization of pimonidazole and the hypoxia-regulated protein carbonic anhydrase 9. Tumor blood perfusion, cellular proliferation, and vascularity were visualized using Hoechst 33342, bromodeoxyuridine, and CD31 staining, respectively. In general, tumors of <1 mm diameter were intensely hypoxic, poorly perfused, and possessed little to no vasculature. Larger tumors (similar to 1-4 mm diameter) were well perfused with widespread vasculature and were not significantly hypoxic. Patterns of hypoxia in disseminated peritoneal tumors and i.d. tumors were similar. Levels of hypoxia in microscopic peritoneal tumors were reduced by carbogen breathing. Peritoneal and i.d. tumor models are suitable for studying hypoxia in microscopic tumors. If the patterns of tumor hypoxia in human patients are similar to those observed in these animal experiments, then the efficacy of systemic treatments of micrometastatic disease may be compromised by hypoxic resistance.
引用
收藏
页码:7646 / 7653
页数:8
相关论文
共 41 条
[1]  
Alvarez RD, 2002, CLIN CANCER RES, V8, P2806
[2]  
Beasley NJP, 2001, CANCER RES, V61, P5262
[3]   ARCON:: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas.: The experience of the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC) [J].
Bernier, J ;
Denekamp, J ;
Rojas, A ;
Minatel, E ;
Horiot, JC ;
Hamers, H ;
Antognoni, P ;
Dahl, O ;
Richaud, P ;
van Glabbeke, M ;
Piérart, M .
RADIOTHERAPY AND ONCOLOGY, 2000, 55 (02) :111-119
[4]   Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck [J].
Brizel, DM ;
Sibley, GS ;
Prosnitz, LR ;
Scher, RL ;
Dewhirst, MW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (02) :285-289
[5]   Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma [J].
Chrastina, A ;
Závada, J ;
Parkkila, S ;
Kaluz, T ;
Kaluzová, M ;
Rajcáni, J ;
Patorek, J ;
Pastoreková, S .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (06) :873-881
[6]   Heterogeneity of tumor oxygenation: Relationship to tumor necrosis, tumor size, and metastasis [J].
De Jaeger, K ;
Merlo, FM ;
Kavanagh, MC ;
Fyles, AW ;
Hedley, D ;
Hill, RP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04) :717-721
[7]   Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas [J].
Driessen, A ;
Landuyt, W ;
Pastorekova, S ;
Moons, J ;
Goethals, L ;
Haustermans, K ;
Nafteux, P ;
Penninckx, F ;
Geboes, K ;
Lerut, T ;
Ectors, N .
ANNALS OF SURGERY, 2006, 243 (03) :334-340
[8]   Hypoxia in human colorectal adenocarcinoma: Comparison between extrinsic and potential intrinsic hypoxia markers [J].
Goethals, Laurence ;
Debucquoy, Annelies ;
Perneel, Christiaan ;
Geboes, Karel ;
Ectors, Nadine ;
De Schutter, Harlinde ;
Penninckx, Freddy ;
McBide, William H. ;
Begg, Adrian C. ;
Haustermans, Karin M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01) :246-254
[9]   CALIBRATION OF MISONIDAZOLE LABELING BY SIMULTANEOUS MEASUREMENT OF OXYGEN-TENSION AND LABELING DENSITY IN MULTICELLULAR SPHEROIDS [J].
GROSS, MW ;
KARBACH, U ;
GROEBE, K ;
FRANKO, AJ ;
MUELLERKLIESER, W .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (04) :567-573
[10]   Hypoxia - A key regulatory factor in tumour growth [J].
Harris, AL .
NATURE REVIEWS CANCER, 2002, 2 (01) :38-47